LON:PHP - Primary Health Properties Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Hold
Consensus Price Target: GBX 170.33
Forecasted Upside: 8.22 %
Number of Analysts: 5
Breakdown:
0 Sell Ratings
3 Hold Ratings
2 Buy Ratings
0 Strong Buy Ratings

GBX 157.40 As of 06/17/2021 05:35 PM ET

▼ -0.2 (-0.13%)

1 month | 3 months | 12 months

Get New Primary Health Properties Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for PHP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHP

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

GBX 170.33

▲ +8.22% Upside Potential

This price target is based on 5 analysts offering 12 month price targets for Primary Health Properties in the last 3 months. The average price target is GBX 170.33, with a high forecast of GBX 184 and a low forecast of GBX 155. The average price target represents a 8.22% upside from the last price of GBX 157.40.

Hold

The current consensus among 5 investment analysts is to hold stock in Primary Health Properties. This rating has held steady since April 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
3 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

12/25/2019

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

3/24/2020

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

6/22/2020

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

9/20/2020

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

12/19/2020

0 strong buy ratings
3 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/19/2021

0 strong buy ratings
2 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

5/18/2021

0 strong buy ratings
2 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

6/17/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Details
5/12/2021	Numis Securities	Reiterated Rating	Add	GBX 184	i
5/12/2021	Liberum Capital	Reiterated Rating	Buy		i
2/17/2021	Jefferies Financial Group	Boost Price Target	Buy	GBX 168 ➝ GBX 172	i
7/29/2020	Peel Hunt	Reiterated Rating	Add		i
7/29/2020	Liberum Capital	Reiterated Rating	Buy		i
7/14/2020	Berenberg Bank	Downgrade	Hold	GBX 150 ➝ GBX 155	i
7/9/2020	Liberum Capital	Reiterated Rating	Buy		i
7/9/2020	Peel Hunt	Reiterated Rating	Restricted		i
5/28/2020	Peel Hunt	Reiterated Rating	Add		i
5/11/2020	Liberum Capital	Reiterated Rating	Buy		i
5/6/2020	Berenberg Bank	Reiterated Rating	Buy		i
5/6/2020	Peel Hunt	Boost Price Target	Add	GBX 160 ➝ GBX 175	i
4/15/2020	Peel Hunt	Reiterated Rating	Add		i
4/15/2020	Barclays	Reiterated Rating	Overweight	GBX 168 ➝ GBX 170	i
4/2/2020	Jefferies Financial Group	Upgrade	Buy	GBX 165 ➝ GBX 179	i
4/1/2020	Peel Hunt	Reiterated Rating	Add		i
4/1/2020	Liberum Capital	Reiterated Rating	Buy		i
3/25/2020	Berenberg Bank	Upgrade	Buy		i
3/18/2020	Peel Hunt	Reiterated Rating	Add		i
3/12/2020	Peel Hunt	Reiterated Rating	Add		i
2/13/2020	Barclays	Reiterated Rating	Overweight	GBX 160 ➝ GBX 168	i
2/12/2020	Peel Hunt	Reiterated Rating	Add	GBX 160	i
2/12/2020	Liberum Capital	Reiterated Rating	Buy		i
2/11/2020	Peel Hunt	Reiterated Rating	Add	GBX 160	i
2/5/2020	Peel Hunt	Reiterated Rating	Add		i
2/5/2020	Liberum Capital	Reiterated Rating	Buy		i
1/27/2020	Liberum Capital	Upgrade	Buy	GBX 130 ➝ GBX 185	i
1/17/2020	Jefferies Financial Group	Downgrade	Hold	GBX 147 ➝ GBX 155	i
1/14/2020	Peel Hunt	Reiterated Rating	Add		i
1/7/2020	Peel Hunt	Reiterated Rating	Add		i
12/17/2019	Peel Hunt	Boost Price Target	Add	GBX 145 ➝ GBX 160	i
12/13/2019	Jefferies Financial Group	Reiterated Rating	Buy		i
12/6/2019	Liberum Capital	Reiterated Rating	Hold		i
12/3/2019	Barclays	Initiated Coverage	Overweight	GBX 160	i
12/3/2019	Peel Hunt	Reiterated Rating	Add		i
11/29/2019	Berenberg Bank	Initiated Coverage	Hold	GBX 150	i
11/26/2019	Peel Hunt	Reiterated Rating	Add		i
11/25/2019	Liberum Capital	Reiterated Rating	Hold		i
11/5/2019	Peel Hunt	Reiterated Rating	Add		i
10/22/2019	Peel Hunt	Reiterated Rating	Add		i
10/15/2019	Peel Hunt	Reiterated Rating	Add		i
10/7/2019	Peel Hunt	Reiterated Rating	Add		i
9/26/2019	Peel Hunt	Reiterated Rating	Add		i
9/24/2019	Liberum Capital	Reiterated Rating	Hold		i
9/17/2019	Peel Hunt	Reiterated Rating	Add		i
9/10/2019	Peel Hunt	Reiterated Rating	Add		i
8/27/2019	Peel Hunt	Reiterated Rating	Add		i
8/20/2019	Liberum Capital	Reiterated Rating	Hold		i
8/9/2019	Peel Hunt	Reiterated Rating	Add		i
7/25/2019	Liberum Capital	Reiterated Rating	Hold		i
7/22/2019	Peel Hunt	Reiterated Rating	Add		i
7/15/2019	Peel Hunt	Reiterated Rating	Add		i
7/9/2019	Peel Hunt	Reiterated Rating	Add		i
6/25/2019	Peel Hunt	Reiterated Rating	Add		i
6/17/2019	Peel Hunt	Downgrade	Add	GBX 140 ➝ GBX 145	i
6/11/2019	Peel Hunt	Reiterated Rating	Buy		i
6/4/2019	Peel Hunt	Reiterated Rating	Buy		i
5/28/2019	Peel Hunt	Reiterated Rating	Buy		i
5/14/2019	Peel Hunt	Upgrade	Buy		i
5/8/2019	Peel Hunt	Upgrade	Buy		i
3/25/2019	Liberum Capital	Downgrade	Hold	GBX 125 ➝ GBX 130	i
3/15/2019	Peel Hunt	Reiterated Rating	Under Review		i
1/14/2019	Peel Hunt	Reiterated Rating	Buy		i
1/9/2019	Liberum Capital	Reiterated Rating	Buy		i
1/4/2019	Peel Hunt	Reiterated Rating	Buy		i
12/20/2018	Peel Hunt	Reiterated Rating	Buy		i
12/17/2018	Liberum Capital	Reiterated Rating	Buy		i
12/5/2018	Liberum Capital	Reiterated Rating	Buy		i
10/30/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
10/22/2018	Liberum Capital	Reiterated Rating	Buy		i
9/19/2018	Peel Hunt	Reiterated Rating	Buy		i
9/5/2018	Peel Hunt	Reiterated Rating	Buy		i
9/5/2018	Liberum Capital	Reiterated Rating	Buy		i
7/25/2018	Peel Hunt	Reiterated Rating	Buy		i
7/25/2018	Liberum Capital	Upgrade	Buy		i
7/12/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
6/11/2018	Peel Hunt	Reiterated Rating	Buy		i
5/9/2018	Peel Hunt	Reiterated Rating	Buy		i
5/2/2018	Liberum Capital	Upgrade	Hold	GBX 120	i
4/30/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
4/23/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
3/23/2018	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
2/21/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
2/15/2018	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
2/15/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
1/18/2018	Jefferies Financial Group	Reiterated Rating	Buy	GBX 126	i
1/8/2018	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
1/2/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
12/14/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
12/5/2017	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
11/29/2017	Jefferies Financial Group	Initiated Coverage	Buy	GBX 125	i
8/2/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
7/27/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
7/27/2017	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
4/20/2017	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
4/20/2017	Liberum Capital	Reiterated Rating	Hold	GBX 110	i
3/13/2017	Liberum Capital	Lower Price Target	Hold	GBX 120 ➝ GBX 110	i
2/16/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
2/16/2017	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
2/3/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
11/1/2016	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
7/27/2016	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
7/27/2016	Liberum Capital	Reiterated Rating	Hold	GBX 112	i
7/20/2016	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
7/4/2016	Liberum Capital	Reiterated Rating	Hold	GBX 112	i

(Data available from 6/17/2016 forward)

Primary Health Properties (PHP) is the leading investor in modern healthcare properties in the UK & Ireland. PHP is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP achieve this by investing in healthcare real estate let on long-term leases, backed by a secure underlying covenant funded mostly by government bodies. The Group's portfolio comprises over 480 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.

Today's Range

Now: GBX 157.40

156

157.80

50 Day Range

MA: GBX 151.97

146.80

158

52 Week Range

Now: GBX 157.40

138.20

166

Volume

3,773,120 shs

Average Volume

4,072,460 shs

Market Capitalization

£2.09 billion

P/E Ratio

18.09

Dividend Yield

3.93%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Primary Health Properties?

The following Wall Street analysts have issued research reports on Primary Health Properties in the last year: Berenberg Bank, Jefferies Financial Group Inc., Liberum Capital, Numis Securities Ltd, and Peel Hunt.
View the latest analyst ratings for PHP.

What is the current price target for Primary Health Properties?

3 Wall Street analysts have set twelve-month price targets for Primary Health Properties in the last year. Their average twelve-month price target is GBX 170.33, suggesting a possible upside of 8.1%. Numis Securities Ltd has the highest price target set, predicting PHP will reach GBX 184 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of GBX 155 for Primary Health Properties in the next year.
View the latest price targets for PHP.

What is the current consensus analyst rating for Primary Health Properties?

Primary Health Properties currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PHP, but not buy more shares or sell existing shares.
View the latest ratings for PHP.

What other companies compete with Primary Health Properties?

Other companies that are similar to Primary Health Properties include Chartwell Retirement Residences, NorthWest Health Prop Real Est Inv Trust, Assura, Impact Healthcare REIT and Medicx Fund.

How do I contact Primary Health Properties' investor relations team?

Primary Health Properties' physical mailing address is 5th Fl, Greener House, 66-68 Haymarket, LONDON, SW1Y 4RF, United Kingdom. The real estate investment trust's listed phone number is +44-20-71045599. The official website for Primary Health Properties is www.phpgroup.co.uk.